Informa plc (LON:INF - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 799.66 ($10.76) and traded as high as GBX 889.60 ($11.97). Informa shares last traded at GBX 880 ($11.84), with a volume of 2,065,498 shares traded.
Wall Street Analyst Weigh In
Several research firms recently weighed in on INF. Shore Capital restated a "buy" rating and issued a GBX 930 ($12.51) price objective on shares of Informa in a report on Friday, May 23rd. JPMorgan Chase & Co. began coverage on Informa in a report on Tuesday, July 29th. They issued an "overweight" rating and a GBX 1,020 ($13.72) price objective for the company.
View Our Latest Analysis on Informa
Informa Trading Up 0.3%
The stock has a 50-day moving average of GBX 825.70 and a 200 day moving average of GBX 800.43. The stock has a market cap of £11.46 billion, a PE ratio of 37.50, a price-to-earnings-growth ratio of 0.75 and a beta of 1.12. The company has a quick ratio of 1.70, a current ratio of 0.56 and a debt-to-equity ratio of 31.98.
Informa (LON:INF - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported GBX 30.10 ($0.40) earnings per share (EPS) for the quarter. Informa had a return on equity of 4.75% and a net margin of 9.30%. As a group, sell-side analysts anticipate that Informa plc will post 59.3240265 earnings per share for the current year.
Insider Buying and Selling at Informa
In other news, insider Stephen A. Carter sold 406,936 shares of the company's stock in a transaction that occurred on Tuesday, July 29th. The stock was sold at an average price of GBX 865 ($11.63), for a total transaction of £3,519,996.40 ($4,734,359.65). 0.53% of the stock is currently owned by insiders.
About Informa
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
Read More
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.